High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

Similar documents
Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Doxorubicin & Ifosfamide

Oral cyclophosphamide in ovarian cancer

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours.

Mitomycin C and Fluorouracil

Gemcitabine and Cisplatin (urology)

Vinblastine (Lymphoma)

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Vinorelbine (Oral) Oral Vinorelbine

ALL Consolidation (cycles 1-4)

Oral Etoposide (Lymphoma)

Brentuximab vedotin. Brentuximab vedotin

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer)

High dose cytarabine (Lymphoma)

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Epirubicin. Epirubicin

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days

Fluorouracil and calcium folinate (Includes MdG (Modified degramont))

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles.

Paclitaxel (Taxol) and carboplatin

Gemcitabine and carboplatin (Lung)

Your treatment. 240 BEP 3 Days Page 1 of 6

Cisplatin and radiotherapy to the

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

tumours tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours

Myeloma Haematology and Transplant Unit

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC)

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles.

Gemcitabine and carboplatin (Lung)

Cisplatin and gemcitabine (GI)

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6

Pemetrexed (Alimta )

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

Sorafenib (Nexavar ) For thyroid carcinoma

Abemaciclib (Verzenios ) Abemaciclib (Verzenios )

Pemetrexed (Alimta ) and cisplatin

Gemcitabine and carboplatin (Breast)

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.

The treatment is given every 3 weeks for 6 to 8 cycles.

Pazopanib (Votrient ) oral for renal tumours

Cisplatin and 5-Fluorouracil (Urology)

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Capecitabine (breast)

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

GDP GDP Gemcitabine, Dexamethasone, CisPlatin Your treatment Day 1 Days 1 to 4 Day 8 dexamethasone

Myeloma Haematology and Transplant Unit CTD1

Docetaxel (Taxotere) with GCSF

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma)

Treatment FLAG. An information guide

Cisplatin and Capecitabine

Alectinib (Alecensa ) Alectinib (Alecensa )

Myeloma Haematology and Transplant Unit MPT

Ibrutinib (Imbruvica )

Ceritinib (Zykadia )

DHAP DHAP Your treatment dexamethasone Possible side effects

Carboplatin and Capecitabine

Pentostatin (Nipent )

IVAC IVAC (Lymphoma) 1277 IVAC (Lymphoma) Page 1 of 6

Docetaxel (Taxotere) & Carboplatin

Eribulin (Halaven ) Treatment is given on Day 1 and Day 8 of a 21-day cycle.

Capecitabine and radiotherapy (colo-rectal)

Mitomycin C by bolus [short] injection followed by capecitabine tablets which can be started the next day.

Treatment FLAG-IDA. An information guide

Nivolumab. Nivolumab

Erlotinib (Tarceva )

Treatment FLAG. An information guide

Tamoxifen Tamoxifen. Your treatment Your doctor or nurse clinician has prescribed for you a treatment which includes the hormonal therapy tamoxifen.

Trastuzumab (Early breast cancer)

Hyper-CVAD per CV Your treatment Your treatment is usually given over five days as an inpatient and consists of:

Eribulin (Halaven ) Treatment is given on Day 1 and Day 8 of a 21-day cycle.

Concurrent chemo-radiation for SCLC

r CVAD Hyper-CVAD Your treatment Your treatment is usually given over five days as an inpatient and consists of:

Pre-operative chemo-radiotherapy to the oesophagus (gullet) Paclitaxel (Taxol) and carboplatin

Dabrafenib and Trametinib

Treatment CODOX-M. An information guide

1231 Zoledronic acid in early breast cancer Page 1 of 5

Chemo-radiotherapy to the stomach post operatively with Capecitabine

Oxaliplatin and capecitabine ecitabine Your treatment latin and ca two

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12

Chemo-radiotherapy to the oesophagus (gullet) Cisplatin & Capecitabine

Etoposide Cisplatin / Etoposide, Methotrexate, Actinomycin

Information for patients having radiotherapy to the whole brain

Dabrafenib (Tafinlar )

Having a gastroscopy A guide for patients and their carers

Haematology. C = Cyclophosphamide (pronounced sigh clo fos fa mide)

Hospital No. Weston Park Hospital contact number

Ketorolac injection. Supportive care

Low dose cytarabine (Low dose Ara C) Cancer Services Information for patients

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card)

Leflunomide Treatment Rheumatology Patient Information Leaflet

Haematology. R - CEPP Chemotherapy

Intravenous anti-cancer treatment

Haematology. The other 2 drugs, folinic acid and GCSF, help to reduce the side effects of the treatment.

Oral anti-cancer treatment

Insertion of a totally implantable vascular access device (TIVAD)

Transcription:

High dose melphalan conditioning for autologous transplant (inpatient) High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre This leaflet is offered as a guide to you and your family. You may find it useful to refer to the booklet Chemotherapy: a guide that gives general information on chemotherapy and side effects. Before you can receive your transplant, your bone marrow and immune system need to be prepared to make way for the new cells. This is called conditioning. Your new cells will be scheduled for re-infusion into you the day after the conditioning therapy has finished. Your treatment will be fully explained to you and your family in clinic by your doctor or one of the nurses from the transplant team who will be happy to answer any questions. If you do not already have a central venous catheter you will need one inserting before starting the conditioning regimen. This is organised by one of the team and will usually be performed on the day of your admission. Your treatment Your doctor has prescribed for you a treatment called melphalan conditioning This involves giving chemotherapy into a vein via a drip on the day after your admission to hospital. Day -2 Day -1 Day -0 Day +10 Day +100 Admission to the Palatine ward and central line insertion Intravenous melphalan with hydration Harvested stem cells re-infused Commence GCSF subcutaneous (under the skin) injection Re-vaccination schedule to begin with G.P. High dose melphalan can make you feel nauseous and cause vomiting. This should improve 24 hours after the infusion has stopped. However, you may continue to experience some degree of nausea. This treatment can have serious or possibly life-threatening side effects. It is very important that you report side effects straight away. Don t delay, if you feel unwell inform the nurse looking after you. Once you have been discharged please ring The Christie Hotline on 0161 446 3658. The lines are open 24 hours a day. Page 1 of 5

Increased risk of serious infection: You are vulnerable to infection. When you have been discharge your immunity will be reduced and you will still be at risk of infection. Minor infections can become lifethreatening in a matter of hours if left untreated. Symptoms of infection include fever, shivering, sweats, sore throat, diarrhoea, discomfort when you pass urine, cough or breathlessness. We recommend that you use a digital thermometer so you can check your temperature. You can buy one from your local chemist. If your temperature is 37.5 C or above, or below 36 C or you have symptoms of an infection, contact The Christie Hotline straight away. Possible side effects Chemotherapy can cause many different side effects. Some are more likely to occur than others. Everyone is different and not everyone gets all the side effects. Most side effects are usually temporary, but in some rare cases they can be life-threatening. It is important to tell your doctor or nurse about any side effects so they can be monitored and, where possible, treated. Common side effects (more than 1 in 10) Anaemia is a low number of red blood cells While having your high dose chemotherapy you may become anaemic. This may make you feel tired and breathless. Let the doctor or nurse know if you experience these symptoms. You will have daily blood tests to monitor this. You may need a blood transfusion. Bruising or bleeding This treatment can reduce the production of platelets which help the blood clot. Let the doctor or nurse know if you have any unexplained bruising or bleeding, such as nosebleeds, bloodspots or rashes on the skin, and bleeding gums. You will have daily blood tests and daily visual checks by the nurses to monitor this whilst an inpatient. You may need a platelet transfusion. Nausea and vomiting (sickness) The severity of this varies from person to person. Anti-sickness medication may be given to you through your line or as a tablet to prevent this. If you continue to feel or be sick inform the doctor or nurse and alternative medications can be prescribed. Hair loss Hair loss is usually total. The hair falls out gradually 10 to 14 days following your infusion of Melphalan. The time scale varies from person to person. This is a temporary side effect and your hair will grow back however the colour and texture may alter. Very rarely, hair loss can be permanent. A wig can be provided. If you would like an appointment with the wig service, this can be arranged for you. The Maggie s centre holds head care workshops telephone 0161 641 4848. Page 2 of 5

Altered taste and smell Chemotherapy can alter your taste and smell. Sometimes altered taste can be described as metallic or bitter. Your sense of taste and smell will normally return but can take some time. Lethargy You will feel tired and lacking in energy. It can be frustrating when you feel unable to cope with routine tasks. Gentle exercise can be beneficial. The nurse will advise and provide information to support you during your stay in hospital. This may last for several weeks after your transplant. Diarrhoea High dose melphalan may cause you to develop severe diarrhoea. If you do, it is important to inform the doctor or nurse looking after you as this may be a sign of infection. Skin changes You may develop a rash or itchy skin. Some chemotherapy can make your skin more sensitive to the sun than usual. Sit in the shade, avoid too much sun and use a high factor sun block cream. Asian and African-Caribbean people may develop noticeable light patches on their skin. Mouth care / mucositis When you begin your conditioning therapy we will give you some products to use that will help to prevent infections in your mouth. Your mouth will become sore or dry and you may notice mouth ulcers. It is important to maintain good oral hygiene, drinking regular fluids and regular teeth brushing with a soft toothbrush. If you have difficulty with you mouth care let your nurse know. You may develop mucositis. This occurs when the mucous membrane lining of your mouth and throat become inflamed and ulcerated. This can be painful and you may need strong painkillers. Diet It is important to try to eat while you are in hospital having treatment. Eating well helps to ensure that your body has the energy and nutrients needed to rebuild damaged tissue, fight infection and cope with any treatment side-effects. Your treatment will increase your risk of infection and certain foods can carry germs which may be harmful to you at this time. As a precaution you will be advised to avoid certain higher risk foods. This information is provided in the booklet Welcome to The Palatine ward. It is usual to experience weight loss during your transplant as your appetite can be reduced. Eating little and often can help. Food supplements are available and a dietitian may come and see you. Rare side effects (less than 1 in 100) Serious and potentially life threatening side effects In a small proportion of patients chemotherapy can result in very severe side effects which may rarely result in death. The team caring for you will discuss the risk of these side effects with you. Page 3 of 5

Sex, contraception & fertility Sexuality The effects of chemotherapy and your transplant can cause sexual problems and may affect your fertility. Loss of sexual desire, changes in hormone levels and for women vaginal dryness, painful intercourse and early menopause are possible. Please discuss any of your concerns with one of the team. Further information is in the booklet Welcome to The Palatine ward. Protecting your partner and contraception: If you are having sexual intercourse we recommend that condoms are used for the period that you will be receiving chemotherapy. Chemotherapy is dangerous to unborn babies and this will also protect you and your partner from any chemotherapy drugs that may be present in semen and in the vagina. If you suspect that you may be pregnant please tell your doctor immediately. For some treatments it is advised that contraception is used and pregnancy avoided for 6 to 12 months after the last dose of treatment. If you have received one of these treatments the medical team will discuss this with you. Fertility Melphalan chemotherapy will affect your ability to have children. Your doctor or nurse should have discussed this with you. If not, please ask them before you start treatment. Late side effects Some side effects may become evident only after a number of years. In reaching any decision with you about treatment, the potential benefit you receive from treatment will be weighed against the risks of serious long term side effects to the heart, lungs, kidneys and bone marrow. With some drugs there is also a small but definite risk of developing another cancer. If any of these problems specifically applies to you, the doctor will discuss these with you and note this on your consent form. Contacts If you have any general questions or concerns about your treatment, please contact The Palatine Treatment Centre. Transplant coordinators 0161 446 8011 Apheresis coordinator 0161 446 8011 Haematology and transplant unit 0161 446 3925 General enquiries 0161 446 3000 For urgent advice ring The Christie Hotline 0161 446 3658 (24 hours) Your consultant is:... Your hospital number is:... Your key worker is:... Page 4 of 5

If you need information in a different format, such as easy read, large print, BSL, braille, email, SMS text or other communication support, please tell your ward or clinic nurse. Contact The Christie Hotline for urgent support and specialist advice The Christie Hotline: 0161 446 3658 Open 24 hours a day, 7 days a week We try to ensure that all our information given to patients is accurate, balanced and based on the most up-to-date scientific evidence. If you would like to have details about the sources used please contact patient.information@christie.nhs.uk 2017 The Christie NHS Foundation Trust. This document may be copied for use within the NHS only on the condition that The Christie NHS Foundation Trust is acknowledged as the creator. For more information about The Christie and our services, please visit www.christie.nhs.uk or visit the cancer information centres at Withington, Oldham or Salford. The Christie NHS Foundation Trust Wilmslow Road Withington Manchester M20 4BX Tel: 0161 446 3000 www.christie.nhs.uk The Christie Patient Information Service July 2017 - Review July 2020 CHR/CT/HTU/960/29.01.13 Version 3 Page 5 of 5